Search

everythinglearnresearchcommunity

for

Search:↓

Men with early hair loss have similar hormone levels to women with PCOS, possibly increasing risk of obesity and heart issues.

AMH is a reliable marker for diagnosing PCOS.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

Polygenic risk scores can predict the risk and outcomes of benign prostatic hyperplasia.

The right balance of Myo-Inositol to D-Chiro-Inositol in follicular fluid is crucial for good egg and embryo quality.

Probiotics and synbiotics may help with PCOS symptoms, but more research is needed.

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

Skin changes during pregnancy are common, and non-invasive imaging is safe for monitoring these changes.

Early hair loss might indicate insulin resistance.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

Early screening and a mix of treatments help manage postpartum depression.

Acanthosis nigricans is common in obese individuals, but not significantly linked to obesity type.

Hair biomarkers can help assess chronic stress in women's reproductive health but need standardized methods and regional studies.

Men seeking hair transplants show higher perfectionism and body dysmorphic disorder symptoms.

Smoking worsens lipid profiles and white blood cell counts and lowers prolactin in women with PCOS.

Diagnosing and treating PCOS is complex due to differing criteria and requires a team approach.

PCOS is linked to obesity and inflammation, increasing cardiovascular risk.

PCOS women with COVID-19 have higher cardiometabolic risks.

Androgenetic alopecia in teens is linked to obesity and other metabolic risks, needing early diagnosis and management.

Maternal stress during pregnancy affects a child's stress levels.

Certain MC4R gene variants are linked to higher BMI in obese women with PCOS but do not cause PCOS.

PCOS is a common hormonal disorder in women, often involving menstrual issues and increased diabetes risk, managed through lifestyle changes and targeted treatments.

Higher cholesterol levels increase aggressive prostate cancer risk.

About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.

Early hair loss in young men is linked to higher risk of metabolic syndrome.

Platelet-rich plasma infusion improved pregnancy outcomes for women with thin endometrium.

Oriental herbal medicine with moxibustion may improve pregnancy rates and other symptoms in PCOS, but more high-quality research is needed.

Hirsutism, excessive hair growth in women, often caused by high androgen levels and polycystic ovary syndrome, can be treated with medication and weight management.

PCOS affects multiple organs and requires combined treatment with lifestyle changes, metformin, and oral contraceptives.

Late puberty may slightly lower prostate cancer risk, baldness is not linked to overall risk but less so with aggressive types, ibuprofen use may increase risk, and vitamins show no effect on risk.